People: Biogen Idec Inc (BIIB.O)

BIIB.O on Nasdaq

389.16USD
30 Jan 2015
Change (% chg)

$35.91 (+10.17%)
Prev Close
$353.25
Open
$372.75
Day's High
$397.00
Day's Low
$372.75
Volume
4,029,782
Avg. Vol
1,798,800
52-wk High
$397.00
52-wk Low
$272.02

Search Stocks

Koppel, Adam 

Brief Biography

Dr. Adam M. Koppel, M.D., Ph.D. has been appointed as Senior Vice President and Chief Strategy Officer of the Company effective May 15, 2014. Dr. Koppel will join Biogen Idec from Brookside Capital, the public equity affiliate of Bain Capital, where he joined in 2003, serving as a managing director since 2009. Prior to Brookside Capital, he was an associate principal of the McKinsey Healthcare Practice. He holds Bachelor and Master of Arts degrees in History and Science from Harvard College and earned an M.D. and Ph.D. in Molecular Neurobiology from the University of Pennsylvania. He also received an M.B.A. from the University of Pennsylvania’s Wharton School.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stelios Papadopoulos

--

George Scangos

15,015,100

Paul Clancy

4,486,260

Kenneth Di Pietro

3,254,520

Susan Alexander

2,162,200

John Cox

3,671,600
As Of 30 Dec 2013
Search Stocks